146 related articles for article (PubMed ID: 38175370)
21. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Lin N; Ku W; Song Y; Zhu J; Lu Z
Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
[TBL] [Abstract][Full Text] [Related]
22. Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.
George LC; Rowe M; Fox CP
Curr Hematol Malig Rep; 2012 Dec; 7(4):276-84. PubMed ID: 22983913
[TBL] [Abstract][Full Text] [Related]
23. Loss of LEF-1 expression as a diagnostic indicator for extranodal NK/T-cell lymphoma: An immunohistochemical study of 88 cases.
Qiu C; Du G
Eur J Haematol; 2022 Nov; 109(5):513-518. PubMed ID: 35871391
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
[TBL] [Abstract][Full Text] [Related]
25. Mature T/NK-Cell lymphomas of the oral and maxillofacial region: A multi-institutional collaborative study.
de Arruda JAA; Abrantes TC; Cunha JLS; Roza ALOC; Agostini M; Abrahão AC; Canedo NHS; Ramos DD; Milito CB; Pontes FSC; Pontes HAR; Barra MB; Zanella VG; Martins MAT; Martins MD; Israel MS; Freire NA; Barreto MEZ; Sánchez-Romero C; Carlos R; Abreu LG; Vargas PA; de Almeida OP; Fonseca FP; Romañach MJ; Mesquita RA; de Andrade BAB
J Oral Pathol Med; 2021 Jul; 50(6):548-557. PubMed ID: 34091947
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
27. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
31. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
32. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.
Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS
Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879
[TBL] [Abstract][Full Text] [Related]
33. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
34. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus DNA measurement in skin tumor lesions might be a sensitive diagnostic marker of recurrence in patients with nasal-type extranodal NK/T-cell lymphoma: A case report.
Yokota N; Kondo M; Matsushima Y; Habe K; Yamanaka K
J Dermatol; 2023 Sep; 50(9):e285-e286. PubMed ID: 36938658
[No Abstract] [Full Text] [Related]
36. How we treat NK/T-cell lymphomas.
Tse E; Zhao WL; Xiong J; Kwong YL
J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
[TBL] [Abstract][Full Text] [Related]
37. Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics.
Wang Y; Zhang M; Xue Q; Zhou H; Chen J; Wang H; Zhang Y; Shi W
Front Immunol; 2023; 14():1172307. PubMed ID: 37138889
[TBL] [Abstract][Full Text] [Related]
38. Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
Halabi MA; Jaccard A; Moulinas R; Bahri R; Al Mouhammad H; Mammari N; Feuillard J; Ranger-Rogez S
Int J Cancer; 2016 Aug; 139(4):793-802. PubMed ID: 27061907
[TBL] [Abstract][Full Text] [Related]
39. Peripheral T cell lymphoma of the nasopharynx with expansion of EBV-positive B cells masquerading as an extranodal NK/T cell lymphoma, nasal type.
Kim HN; Kim DS; Jeon MJ; Yu ES; Choi CW; Ko YH
Virchows Arch; 2022 Jul; 481(1):125-129. PubMed ID: 34997312
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological features of primary EB virus positive nodal T/NK cell lymphoma].
Wang GN; Zhao WG; Zhang DD; Zhang YP; Huang XJ; Li WC
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1009-1014. PubMed ID: 32992414
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
